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Background: Although hypercholesterolemia is a major risk factor for coronary artery disease (CAD), only limited
data are available regarding its direct effect on myocardial function apart from CAD. The aim of this study was to
evaluate LV systolic function using speckle-tracking echocardiography and investigate the relationship between
hypercholesterolemia and myocardial function.
Methods: Twenty-eight rabbits were randomly divided into three groups: 8 were fed normal chow for 3 months
(group 1) and the remaining 20 were fed an atherogenic diet for 2 (group 2) or 3 months (group 3). Global systolic
radial, circumferential and longitudinal peak strain were calculated. Serum total cholesterol (TC), low density
lipoprotein cholesterol (LDL-C) and myocardial cholesterol levels were measured.
Results: Global systolic longitudinal strain were both decreased in the group 2 and 3 (P < 0.001), whereas radial
strain were increased (P < 0.001) compared with group 1. Global circumferential strain in the group 3 was
significantly reduced (P < 0.001). Serum and myocardial cholesterol concentration markedly increased in the group
2 and group 3 (P < 0.001). There was a significant inverse correlation between longitudinal strain and serum TC,
LDL-C as well as myocardial cholesterol levels (r = − 0.723, r = − 0.794, r = − 0.700, P both < 0.001). A significant
negative correlation was also noted between circumferential strain and serum TC, LDL-C as well as myocardial
cholesterol levels (r = − 0.518, P = 0.007; r = − 0.691, P < 0.001; r = − 0.659, P < 0.001). A significant positive correlation
was found between radial strain and serum TC, LDL-C as well as myocardial cholesterol levels (r = 0.432, P = 0.028;
r = 0.602, P = 0.001; r = 0.469, P = 0.016).
Conclusion: Although LV morphology and ejection fractions were not different among the three groups, elevated
concentration of cholesterol, especially in serum LDL-C, was significantly associated with LV systolic dysfunction. The
findings also indicate that reductions in longitudinal was the first appeared, followed by circumferential, and was
compensated for by increasing radial strain.
Keywords: Hypercholesterolemia, Myocardial function, Speckle tracking echocardiographyBackground
Although hypercholesterolemia has emerged as a strong
risk factor for coronary artery disease (CAD) [1-3],
only limited data are available regarding its direct effect
on myocardial function apart from CAD [4-6]. The
metabolic derangement of hypercholesterolemia can
result in abnormalities of cardiac function that are* Correspondence: mym1234@126.com
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unless otherwise stated.likely independent of effects on the vasculature [5].
While single left ventricular (LV) myocytes isolated from
hypercholesterolemic rabbits demonstrated a significant
reduction in systolic function without any change in blood
pressure or LV morphology [4], few data are available
from in vivo investigations.
Speckle tracking echocardiography (STE), a relatively
new echocardiographic imaging modalities, offers an
objective and quantitative evaluation of global and
regional myocardial deformation in longitudinal, radial
and circumferential directions [7-9]. A large amount ofThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Systolic radial stain of the six myocardial segments.
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subtle changes in LV function at an early subclinical
stage [10-13].
The aim of the present study was to elucidate whether
dietary hypercholesterolemia alters LV systolic function




The experimental protocol was approved by a local
ethical committee (First Affiliated Hospital, Xinjiang
Medical University, Xinjiang, China). Twenty-eight male
New Zealand rabbits (1.9-2.3 kg) were housed in separate
cages in an environmentally controlled facility (AAALAC
accredited) and were given water ad libitum and received
humane care in compliance with institutions guidelines.
The rabbits were acclimatized to laboratory conditions for
7 days prior to treatment. Eight rabbits were fed normal
chow for 3 months as control (group 1) and the remaining
20 accepted an atherogenic diet for 2 months (group 2) orTable 1 General characteristics of the study animals
Parameters Group 1 n = 8 Group 2 n = 10
HR (beats/min) 183.50 ± 9.49 168.30 ± 9.32
SBP (mmHg) 109.88 ± 11.31 110.50 ± 8.37
DBP (mmHg) 78.25 ± 8.05 77.50 ± 10.84
HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure.3 months (group 3). The atherogenic diet contained 84%
standard chow diet, 5% lard, 5% egg yolk powder and 2%
cholesterol [13]. Diarrhea, appetite and coat color were
observed during the experimental period.
Echocardiographic imaging
On the day of the study, rabbits fast for approximately
4 h to reduce abdominal distention and to facilitate
obtaining the images. Echocardiographic images were
acquired after lightly sedated with 10 mg/kg ketamine
(Fujian Gutian Pharmaceutical Co., Ltd, China), 1 mg/kg
Diazepam (Tianjin Jinyao Amino Acid Co., Ltd, China)
and 0.025 mg/kg Atropine (Tianjin Pharmaceutical Group
Co., Ltd, China) administered intravenously. The rabbits
were placed in prone position without restraint. All
images were obtained using a commercial ultrasound
machine (Vivid 7 Dimension; GE Vingmed Ultrasound
AS, Horten, Norway) with an M5S probe. M- mode
images of parasternal long-axis view, B-mode images of
apical three-chamber, four-chamber, and two-chamber
views, short-axis views at the level of the mitral valve,Group 3 n = 9 F-value P-value
187.89 ± 11.02 2.21 0.13
111.22 ± 10.33 0.12 0.88
82.67 ± 10.06 0.73 0.49








LVEDd (mm) 13.14 ± 1.43 13.51 ± 1.69 13.33 ± 1.58 0.12 0.89
LVEDs (mm) 8.62 ± 0.86 9.00 ± 1.02 8.81 ± 0.92 0.37 0.70
IVS (mm) 2.12 ± 0.31 1.88 ± 0.36 2.08 ± 0.37 1.28 0.30
PW (mm) 2.04 ± 0.22 2.01 ± 0.20 2.23 ± 0.38 1.63 0.22
LVEF (%) 67.38 ± 4.63 65.97 ± 4.61 66.93 ± 3.73 0.25 0.78
LAD (mm) 8.84 ± 1.15 9.94 ± 1.23 9.42 ± 0.99 0.66 0.53
LVEDd, left-ventricular end-diastolic diameter; LVEDs, left-ventricular end-
systolic diameter; EF, ejection fraction; LAD, left-atrial diameter; IVS, ventricular
septal end-diastolic thickness; PW, posterior wall end-diastolic thickness.
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stored in cine-loop format for off line analysis [14]. LV
end-diastolic diameter (LVEDd), LV end-systolic diameter
(LVEDs), septal and LV posterior wall thickness, and left
atrial anteroposterior diameter (LAD) were measured from
standard planes. LV ejection fraction (EF) was calculated
with the Teicholz formula [15].Table 3 Peak systolic longitudinal strain values
Longitudinal strain (%) Group 1 n = 8 Group 2 n =
A4C septum
Basal segment −21.76 ± 3.28 −21.97 ± 4.0
Mid segment −23.40 ± 4.38 −21.89 ± 3.4
Apical segment −24.54 ± 5.57 −22.08 ± 4.3
A4C lateral wall
Basal segment −23.64 ± 4.44 −21.96 ± 3.3
Mid segment −20.88 ± 3.74 −20.98 ± 3.2
Apical segment −22.94 ± 3.36 −21.90 ± 3.4
A3C posterior wall
Basal segment −22.74 ± 3.21 −20.89 ± 2.3
Mid segment −21.71 ± 2.68 −22.05 ± 2.6
Apical segment −23.77 ± 2.78 −21.15 ± 3.4
A3C anterior septum
Basal segment −21.31 ± 3.34 −20.92 ± 3.5
Mid segment −21.96 ± 2.95 −21.09 ± 3.7
Apical segment −22.28 ± 2.24 −22.59 ± 2.8
A2C inferior wall
Basal segment −25.78 ± 4.34 −20.90 ± 2.7
Mid segment −23.37 ± 4.53 −20.02 ± 2.5
Apical segment −24.54 ± 4.51 −21.23 ± 2.3
A2C anterior wall
Basal segment −23.64 ± 4.28 −21.75 ± 2.3
Mid segment −23.17 ± 3.39 −23.37 ± 2.6
Apical segment −24.28 ± 5.70 −23.59 ± 3.9
Data are expressed as mean ± SD. A4C, Apical four-chamber; A3C, apical three-cham
▲p < 0.05 for group 3 vs. group 2.Strain analysis
Two-dimensional B-mode images were captured with
a frame rate of 50–80 fps and five beats were recorded
for analysis. Blinded offline analyses of the short-axis
views and apical long-axis views were performed
using EchoPAC PC version 6.1.1 (GE Vingmed Ultra-
sound AS, Horten, Norway). After selecting the best-
quality image of the cardiac cycle, the LV endocardial
border was manually traced at the end-systolic frame,
from which a speckle-tracking region of interest was
automatically selected to approximate the myocardium
between the endocardium and epicardium [16]. The
workstation then computed and generated strain curves.
The software automatically divided the sectional
image into six segments according to the statement
of the Cardiac Imaging Committee of the Council on
Clinical Cardiology of the American Heart Association
[17] (Figure 1). Strain curves of three consecutive car-
diac cycles and values were imported for further ana-
lysis. To determine global longitudinal, circumferential
and radial strain, the strain values of the 18 segments10 Group 3 n = 9 F-value P-value
8 −18.87 ± 2.15 2.240 0.129
7 −18.91 ± 2.20* 3.493 0.047
2 −19.41 ± 3.06* 2.685 0.090
1 −18.30 ± 1.69*▲ 5.382 0.019
0 −18.32 ± 2.01 1.945 0.166
8 −19.28 ± 4.21 2.115 0.143
8 −18.87 ± 3.35* 3.425 0.050
5 −18.57 ± 3.13*▲ 3.924 0.034
7 −21.60 ± 4.27 1.327 0.285
4 −19.41 ± 2.79 0.764 0.477
0 −19.62 ± 3.68 0.837 0.446
7 −18.86 ± 3.55*▲ 4.197 0.028
4* −19.36 ± 3.19* 7.749 0.003
9 −19.08 ± 3.61* 3.205 0.059
4 −21.57 ± 4.23 2.027 0.155
4 −18.96 ± 3.24* 4.066 0.031
8 −17.82 ± 3.00*▲ 9.140 0.001
0 −21.10 ± 4.14 1.075 0.358
ber; A2C, apical two-chamber. *p < 0.05 for group 3 and group 2 vs. group 1,
Table 4 Peak systolic circumferental strain values
Circumferental strain (%) Group 1 n = 8 Group 2 n = 10 Group 3 n = 9 F-value P-value
Mitral valve level
Anteroseptal wall −30.18 ± 5.52 −30.33 ± 5.91 −23.45 ± 6.55*▲ 3.571 0.045
Anterior wall −23.76 ± 4.86 −23.22 ± 4.42 −20.09 ± 2.33 1.939 0.167
Lateral wall −20.63 ± 5.89 −19.75 ± 3.35 −19.10 ± 3.19 0.263 0.771
Posterior wall −21.40 ± 4.46 −20.85 ± 4.58 −18.65 ± 3.25 0.869 0.433
Inferior wall −22.58 ± 4.22 −20.89 ± 4.59 −17.34 ± 3.73* 3.215 0.059
Septal wall −27.99 ± 6.30 −27.83 ± 6.71 −21.75 ± 4.45*▲ 2.937 0.073
Papillary level
Anteroseptal wall −28.22 ± 7.03 −29.73 ± 6.00 −24.80 ± 4.06 1.619 0.22
Anterior wall −20.58 ± 3.78 −22.99 ± 4.44 −19.76 ± 2.89 1.776 0.192
Lateral wall −18.99 ± 3.19 −20.18 ± 3.17 −18.31 ± 2.04 0.982 0.39
Posterior wall −19.32 ± 3.52 −19.73 ± 3.31 −19.45 ± 1.06 0.047 0.954
Inferior wall −21.01 ± 3.60 −20.59 ± 2.33 −17.19 ± 1.89*▲ 5.047 0.015
Septal wall −27.98 ± 7.59 −28.21 ± 5.53 −20.66 ± 3.03*▲ 4.717 0.019
Apical level
Anteroseptal wall −30.24 ± 6.67 −28.71 ± 6.29 −21.53 ± 3.78*▲ 5.284 0.013
Anterior wall −25.66 ± 5.46 −23.68 ± 5.03 −19.68 ± 2.60* 3.539 0.046
Lateral wall −24.88 ± 4.33 −22.72 ± 6.18 −19.48 ± 3.25* 2.192 0.134
Posterior wall −25.33 ± 5.92 −23.65 ± 3.84 −19.49 ± 3.06* 3.782 0.038
Inferior wall −25.81 ± 5.45 −23.46 ± 5.93 −18.66 ± 2.86* 4.228 0.027
Septal wall −26.64 ± 6.78 −27.42 ± 6.34 −24.85 ± 5.08 0.553 0.582
Data are expressed as mean ± SD. *p < 0.05 for group 3 and group 2 vs. group 1, ▲p < 0.05 for group 3 vs. group 2.
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views.Blood pressure measurement
After echocardiographic imaging, blood pressure
measurements were made from the central ear artery
(CEA) of rabbits using a 20G vascular catheter
(Johnson and Johnson, Belgium). The arterial catheter
was connected to a pressure transducer (MLT0699, AD
Instruments, Pty Ltd, Australia) and an analog-to-digital
converter (PowerLab, ML866, AD Instruments, Pty
Ltd, Australia). Arterial systolic and diastolic pressure
were recorded.Cholesterol analysis
Peripheral blood was collected from ear veins with
a 25-gauge needle and syringe at baseline, 2 months
and 3 months. Total cholesterol (TC) and low
density lipoprotein cholesterol (LDL-C) were mea-
sured with an automated clinical chemistry analyzer
(AU680, Beckman Instruments, USA). All rabbits
were euthanized at correspnding time and the hearts
removed. A segment of myocardial tissue (10 × 3 mm)
from the LV free wall was excised. Cholesterol levels weremeasured in the tissue segment using a cholesterol Kit
(EnzyChrom Cholesterol Assay Kit, BioAssay Systems,
Hayward, CA).Statistical analysis
SPSS 16.0 (SPSS inc., Chicago, Illinois, USA) was used
for statistical analysis. The data were tested for normality
and homogeneity of variance. Data are expressed as
mean ± standard deviation (SD). One way ANOVA was
used to compare the echocardiographic parameters, strain
parameters, myocardial and serum cholesterol levels
for all three groups. Pearson correlation analysis was
done between STE variables and cholesterol levels. For
all analyses, a P value < 0.05 was considered significant.
Interobserver and intraobserver variability for strain
measurements were examined using both Pearson’s
bivariate two-tailed correlations and Bland-Altman
analysis from 10 randomly selected rabbits.Results
Animal
Of the 28 experimental rabbits, 1 died in the group 3
due to diarrhea. Heart rates and blood pressure of three
groups were similar (P > 0.05, Table 1).
Table 5 Peak systolic radial strain values
Radial strain (%) Group 1 n = 8 Group 2 n = 10 Group 3 n = 9 F-value P-value
Mitral valve level
Anteroseptal wall 36.84 ± 6.98 38.88 ± 6.16 45.48 ± 6.85*▲ 3.756 0.039
Anterior wall 37.92 ± 7.15 40.48 ± 8.06 44.77 ± 9.82 1.368 0.275
Lateral wall 41.65 ± 7.78 42.02 ± 9.12 46.48 ± 9.37 0.765 0.477
Posterior wall 39.65 ± 5.41 44.31 ± 7.06 49.07 ± 6.21* 4.426 0.024
Inferior wall 40.92 ± 5.31 42.54 ± 7.64 50.13 ± 7.02*▲ 4.231 0.027
Septal wall 38.09 ± 7.21 40.84 ± 7.21 47.40 ± 5.41* 4.098 0.03
Papillary level
Anteroseptal wall 37.41 ± 5.01 38.11 ± 5.38 44.81 ± 10.12* 2.726 0.087
Anterior wall 37.06 ± 7.45 37.83 ± 6.56 39.28 ± 7.31 0.205 0.816
Lateral wall 42.32 ± 7.81 39.45 ± 7.27 42.05 ± 9.37 0.351 0.708
Posterior wall 42.54 ± 7.14 44.24 ± 3.81 46.22 ± 11.70 0.432 0.654
Inferior wall 43.18 ± 8.54 42.40 ± 4.87 45.67 ± 6.38 0.574 0.571
Septal wall 39.85 ± 8.45 41.14 ± 6.87 48.49 ± 6.96*▲ 3.23 0.058
Apical level
Anteroseptal wall 39.10 ± 6.70 38.63 ± 5.90 43.96 ± 6.63 1.802 0.187
Anterior wall 37.29 ± 6.44 38.84 ± 5.84 44.71 ± 4.59*▲ 3.88 0.035
Lateral wall 43.85 ± 8.84 40.85 ± 3.97 47.66 ± 9.67*▲ 3.159 0.061
Posterior wall 41.17 ± 7.37 41.74 ± 6.88 44.07 ± 12.15 0.241 0.788
Inferior wall 44.52 ± 6.66 42.14 ± 8.85 44.90 ± 7.49 0.336 0.718
Septal wall 42.44 ± 6.06 38.34 ± 5.84 46.96 ± 10.41▲ 2.88 0.076
Data are expressed as mean ± SD. *p < 0.05 for group 3 and group 2 vs. group 1, ▲p < 0.05 for group 3 vs. group 2.
Figure 2 Global peak systolic longitudinal, circumferential and radial strain in the three groups. *p < 0.001 for group 3 vs. group 2 and
group 1. ▲p < 0.05 for group 2 vs group 1.
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Table 6 Serum and tissue cholesterol profiles
Parameters Group 1 n = 8 Group 2 n = 10 Group 3 n = 9 F-value P-value
Serum TC (mmol/L) 2.07 ± 0.60 24.15 ± 5.36* 34.74 ± 10.40*▲ 191.27 0.000
Serum LDL-C (mmol/L) 1.13 ± 0.54 10.73 ± 3.32* 31.62 ± 3.68*▲ 229.60 0.000
Tissue cholesterol(μmol/g) 0.86 ± 0.29 2.22 ± 0.62* 4.92 ± 1.63*▲ 34.68 0.000
Data are expressed as mean ± SD. TC, total cholesterol; LDL-C, low density lipoprotein cholesterol.
*p < 0.05 for group 3 and group 2 vs. group 1, ▲p < 0.05 for group 3 vs. group 2.
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Echocardiographic measurements of the different groups
were shown in Table 2. There were no significant differ-
ences in LVEF, LVEDd, LVEDs, IVS, PW and LAD
among three groups (P > 0.05).
Strain measurements
From a total of 972 analyzed segments, 28 segments
were excluded owing to suboptimal myocardial tracking
and poor image quality. Regional longitudinal (Table 3)
and circumferential (Table 4) strain of LV were significantly
reduced in group 3 compared with group 1 and 2. But
regional radial strain of LV were significantly increased in
group 3 (Table 5).
Global longitudinal myocardial deformation of the LV
was significantly impaired both in group 2 and 3, while
radial deformation was increased in group 3 compared
with group 1 and 2. In addition, global circumferential
strain was also reduced in group 3 compared with group 1
and 2 (Figure 2).
Serum and tissue cholesterol profiles
The serum cholesterol profiles of the three groups
after experiment were shown in Table 6. There was a
statistically significant increase in serum TC, LDL-C and
tissue cholesterol levels in animals fed with cholesterol
enriched diet compared with the control group (p <0.05).
Morerove, the concentration of cholesterol increased with
feeding duration (p <0.05).
Correlation between strain parameters and cholesterol
levels
The correlation between strain parameters and cholesterol




Serum TC Serum LDL -C Tissue cholesterol
r p r p r p
GLS −0.723 0.000 −0.794 0.000 −0.700 0.000
GRS 0.432 0.028 0.602 0.001 0.469 0.016
GCS −0.518 0.007 −0.691 0.000 −0.659 0.000
GLS, global longitudinal strain; GRS, global radial strain; GCS, global
circumferential strain; TC, total cholesterol; LDL-C, low density
lipoprotein cholesterol.correlation between global longitudinal strain and
serum TC, LDL-C as well as myocardial cholesterol levels.
(r = − 0.723, P < 0.001; r = − 0.794, P < 0.001; r = − 0.70,
P < 0.001). A significant negative correlation was also
noted between global circumferential strain and
serum TC, LDL-C as well as myocardial cholesterol
levels. (r = − 0.518, P = 0 .007; r = − 0.691, P < 0.001;
r = − 0.659, P < 0.001). A significant positive correlation
was found between radial strain and serum TC, LDL-C as
well as myocardial cholesterol levels. (r = 0.432, P = 0.028;
r = 0.602, P = 0.001; r = 0.469, P = 0.016).
Reproducibility
The results showed very good intra-observer variability for
longitudinal, circumferential and radial strain rate (r =
0.817, P = 0.004; r = 0.798, P = 0.006; r = 0.868, P = 0.001).
The Bland-Altman plots demonstrated acceptable inter-
observer variability for all strain parameters (Figure 3).
Discussion
To the best of our knowledge, the present study is the first
to comprehensively compare strain parameters-derived
STI with the levels of serum and myocardial cholesterol in
diet-induced expeimental hypercholesterolemia. Although
previous experimental studies have shown that diet-
induced hypercholesterolemia resulted in contractile
reduction of single ventricular myocyte without any change
in pressure or LV morphology [4], few data are available
from in vivo investigations. The present study displayed
the application of STE as a noninvasive imaging technique
to elucidate the direct effect of hypercholesterolemia on
LV myocardial deformation in a rabbit model.
In our study, there were no significant differences
in LV morphology, EF and blood pressure among
groups, whereas LV strain was found to be reduced in
the hypercholesterolemic rabbits. Previous studies
failed to show abnormalities using EF, which may be
due to EF reflects the whole LV systolic function,
under the influence of pre and afterload [18]. With the
application of advanced techniques, such as strain, strain
rate, incipient systolic dysfunction has been detected in
subclinical diseases [19]. Moreover, our analysis indicates
that longitudinal dysfunction are the first appeared,
followed by circumferential, which suggest the importance
of longitudinal strain in the assessment of LV systolic
dysfunction in subclinical stage.
Figure 3 Inter-observer variability for global longitudinal (left), circumferential (middle) and radial strain (right).
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hypercholesterolemia can not confirm from our study.
However, a recent human study demontrated longi-
tudinal and circumferential deformations were both
impaired in the children with heterozygous familiar
hypercholesterolemia [20]. Thus, we believe that the
abnormalities we found in rabbit models with hypercholes-
terolemia indicate an early sign of hypercholesterolemia-
induced myocardial dysfunction, in agreement with the
in vitro expriments [4].
Interestingly, our study demonstrates that the increased
radial deformation make up for impaired longitudinal and
circumferential strain in rabbit hypercholesterolemic
models to maintain LVEF. This finding is consistent
with prior reports in children with heterozygous
familial hypercholesterolemia and other preclinical
diseases [14,20,21]. The potential mechanism by which
hypercholesterolemia causes the increase in radial
deformation remains unclear. A possible explanation
could be the realignments of myocardial fiber orientation
in the outer half of the myocardium may contribute
to “transmural compensation” by less impaired epicardial
fibers [22].
In the present study, a significant negative correlation
were found between global longitudinal strain and serum
cholesterol level as well as myocardial cholesterol levels.
These results indicate that the cholesterol accumulated
in the myocardium may be responsible for a reduction
in myocardial strain. Similar to our study, Wang et al.
[23] reported a positive correlation between serum
HDL levels and LVEF in human subjects with serum
hypercholesterolemia even in the absence of angiographic
evidence of CAD.
The precise mechanism responsible for the association
between cholesterol level and impaired myocardial
deformation cannot be determined from our study.
However, several mechanisms have been proposed to
explain LV dysfunction induced by hypercholesterolemia:
(1) increased cardiac oxidative stress [24], (2) alteration of
the myocardial energy metabolism [22], (3) changes in
myosin heavy-chain isoform expression patterns [4], (4)down-regulation and redistribution of connexin-43 expres-
sion in myocardium [25], and (5) impaired activation of
myocardial adenosine triphosphate-sensitive potassium
channels [19]. These mechanisms may represent the basis
for a “hypercholesterolemic cardiomyopathy [26].Study limitations
As a limitations of our study, administration of ketamine-
Diazepam - Atropine combinations induces mild
bradycardia, which slightly alters cardiac function. In
addition, LV diastolic function, rotation and torsion
mechanics are potentially very important features for
the comprehensive understanding of myocardial tissue
damage; therefore, lack of measurement of diastolic
function, rotation and torsion was another limitation
of the present study.Conclusion
Hypercholesterolemia was significantly associated with
LV myocardial functional alterations apart from CAD.
The findings also indicate that decreases in longitudinal
was the first appeared, followed by circumferential, and
was compensated for by increasing radial strain. Thus, the
application of STE may provide noninvasive functional
insight into disease progression or recovery in reponse to
therapeutic intervention.
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